95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Analyze DCF forecasts for the company and compare them with competitors.
1.31B
Better than OR's revenue of 116.04M.
5.23%
Better than OR's revenue growth rate of -7.48%.
911.75M
Better than OR's ebitda of 55.84M.
69.55%
Better than OR's ebitda margin of 48.12%.
602.81M
Better than OR's ebit of 31.80M.
45.98%
Better than OR's ebit margin of 27.40%.
308.94M
Worse than OR's depreciation of 24.04M.
439.47M
Better than OR's total cash of 59.54M.
33.52%
Worse than OR's cash as percentage of revenue of 51.31%.
11.76M
Worse than OR's receivables of 929.30K.
0.90%
Worse than OR's receivables as percentage of revenue of 0.80%.
18.05M
Worse than OR's inventories of 3.11M.
1.38%
Better than OR's inventories as percentage of revenue of 2.68%.
16.31M
Worse than OR's accounts payable of 3.15M.
1.24%
Better than OR's payables as percentage of revenue of 2.72%.
-295.93M
Better than OR's capital expenditure of -79.61M.
-22.57%
Worse than OR's capex as percentage of revenue of -68.60%.
7.76%
Better than OR's weighted average cost of capital (wacc) of 8.66%.
7.74%
Better than OR's cost of equity of 8.68%.
88.46%
Worse than OR's cost of debt of 9.48%.
0.71
Better than OR's beta of 0.91.
453.46M
Worse than OR's diluted shares outstanding of 185.23M.
6.23M
Better than OR's total debt of 138.33M.
25.95B
Better than OR's total equity of 3.41B.
25.95B
Better than OR's total capital of 3.55B.
0.02%
Better than OR's debt weighting of 3.90%.
99.98%
Better than OR's equity weighting of 96.10%.
602.40M
Better than OR's ebiat of 26.89M.
614.74M
Better than OR's unlevered free cash flow of -28.60M.
2.00%
Equal to OR's long-term growth rate of 2.00%.
10.89B
Better than OR's terminal value of -438.34M.
9.71B
Better than OR's enterprise value of -423.63M.
-540.30M
Better than OR's net debt of 91.46M.
10.25B
Better than OR's equity value of -515.10M.
22.61
Better than OR's equity value per share of -2.78.
Analyze analyst forecasts for the company and compare them with competitors.
1.76B
Better than OR's estimated revenue of 365.30M.
1.22B
Better than OR's estimated ebitda of 175.78M.
2.06
Better than OR's estimated eps of 1.15.
932.09M
Better than OR's estimated net income of 212.44M.
808.79M
Better than OR's estimated ebit of 100.10M.
95.24M
Worse than OR's estimated sg&a expense of 43.34M.
View analysts' price targets and recommendations, and compare them with competitors.
$100.50
Has upside compared to OR's downside of 38.87%.
Buy
Equal to OR's analyst recommendation of Buy.
